Crassula Pharmaceuticals Launches in Honduras

Gasflum 40mg
Crassula Pharmaceuticals Launches Gasflum, Esomeprazole 40mg Coated Tablet, in Honduras

Tegucigalpa, Honduras – Crassula Honduras, a premier pharmaceutical manufacturer, proudly announces the launch of Gasflum, an esomeprazole 40mg coated tablet, enhancing its portfolio of high-quality healthcare solutions in Honduras. Designed for effective management of acid reflux and related conditions, Gasflum offers a significant advancement in treating gastroesophageal reflux disease (GERD), peptic ulcers, and excessive stomach acid production.


Esomeprazole, the active component of Gasflum, is a proton pump inhibitor (PPI) that effectively reduces stomach acid. The coated tablet formulation ensures ease of use and adherence, with a convenient once-daily dosing.


“Crassula Honduras is committed to improving healthcare outcomes with accessible and innovative treatments. Gasflum represents our dedication to providing effective solutions for managing gastrointestinal conditions,” said Dr. Roopesh Gupta, CEO at Crassula Pharmaceuticals. “We aim to enhance the quality of life for patients in Honduras, making advanced care readily available.”


For more details on Gasflum and other products, visit or contact 


About Crassula Honduras


Crassula Honduras specializes in high-quality healthcare products, focusing on innovation, quality, and patient safety to improve health and well-being in Honduras and beyond. Our diverse product range addresses various therapeutic areas, meeting the healthcare needs of our community.

Estarol 20mg
Crassula Pharmaceuticals Launches Estarol, Atorvastatin 20mg and 40mg Coated Tablets, in Honduras

Tegucigalpa, Honduras – Crassula Honduras, a leader in pharmaceutical manufacturing, announces the launch of Estarol, atorvastatin in 20mg and 40mg coated tablets, reinforcing its commitment to advancing cardiovascular health in Honduras. Estarol is formulated to lower high cholesterol and reduce the risk of heart disease, showcasing Crassula Honduras’s dedication to offering comprehensive healthcare solutions.


Atorvastatin, the active ingredient in Estarol, is a statin medication that works by reducing the levels of bad cholesterol (LDL) and triglycerides in the blood while increasing good cholesterol (HDL). The availability of Estarol in both 20mg and 40mg dosages allows healthcare providers to tailor treatment to individual patient needs, enhancing the effectiveness of cholesterol management strategies.


“Estarol is a testament to Crassula Honduras’s ongoing commitment to provide innovative, accessible healthcare solutions,” said Ricardo Fiallos, Sales Director at Crassula Honduras. “With the launch of Estarol, we aim to address the growing need for effective cholesterol management options, contributing to the prevention of cardiovascular diseases and improving patient outcomes in Honduras.”


Estarol’s coated tablet formulation ensures ease of administration and patient compliance, with dosing flexibility to meet the therapeutic needs of a wide patient population.


For more information about Estarol and other Crassula Honduras products, please visit visit or contact 


About Crassula Honduras


Crassula Honduras is committed to delivering high-quality healthcare products, emphasizing innovation, quality, and patient safety to enhance the health and well-being of individuals in Honduras and beyond. Our broad product portfolio addresses various therapeutic needs, fulfilling the healthcare requirements of our community.


2 Responses

Leave a Reply

Your email address will not be published. Required fields are marked *